PE20131063A1 - Composicion acuosa que contiene bromhexina - Google Patents

Composicion acuosa que contiene bromhexina

Info

Publication number
PE20131063A1
PE20131063A1 PE2013000041A PE2013000041A PE20131063A1 PE 20131063 A1 PE20131063 A1 PE 20131063A1 PE 2013000041 A PE2013000041 A PE 2013000041A PE 2013000041 A PE2013000041 A PE 2013000041A PE 20131063 A1 PE20131063 A1 PE 20131063A1
Authority
PE
Peru
Prior art keywords
bromhexin
aqueous composition
composition containing
composition
referred
Prior art date
Application number
PE2013000041A
Other languages
English (en)
Inventor
Uwe Scheuring
Bernd Plohmann
Annette Zamponi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43063562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20131063(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20131063A1 publication Critical patent/PE20131063A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

REFERIDA A UNA COMPOSICION ACUOSA QUE COMPRENDE: a) BROMHEXINA EN UNA CANTIDAD DE 0,04 G A 0,4 G REFERIDA A 100 ML DE LA COMPOSICION, b) UN AGENTE ESPESANTE EN UNA CANTIDAD DE 0,005 G A 5 G, c) UN AGENTE EDULCORANTE EN UNA CANTIDAD DE 0,01 G A 20 G, d) UN AGENTE CONSERVANTE EN UNA CANTIDAD DE 0,01 G A 0,5 G, e) AGUA EN UNA CANTIDAD DE 70% EN PESO. TAMBIEN COMPRENDE OTRAS SUSTANCIAS TALES COMO CONSERVANTES, REGULADORES DE LA ACIDEZ, ANTIESPUMANTE, AROMATIZANTES, ENTRE OTROS. DICHA COMPOSICION TIENE UN pH DE 2,0 A 6,0 Y ES UTIL EN EL TRATAMIENTO DE ENFERMEDADES BRONCOPULMONARES AGUDAS Y CRONICAS
PE2013000041A 2010-07-12 2011-07-07 Composicion acuosa que contiene bromhexina PE20131063A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10169236 2010-07-12

Publications (1)

Publication Number Publication Date
PE20131063A1 true PE20131063A1 (es) 2013-10-12

Family

ID=43063562

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013000041A PE20131063A1 (es) 2010-07-12 2011-07-07 Composicion acuosa que contiene bromhexina

Country Status (26)

Country Link
US (1) US9220693B2 (es)
EP (1) EP2593094B1 (es)
JP (1) JP5979763B2 (es)
KR (1) KR101943812B1 (es)
CN (1) CN103052384B (es)
AR (1) AR082381A1 (es)
AU (1) AU2011278451B2 (es)
BR (1) BR112013000537B1 (es)
CA (1) CA2803471C (es)
CL (1) CL2012003625A1 (es)
CO (1) CO6680609A2 (es)
CY (1) CY1120079T1 (es)
DK (1) DK2593094T3 (es)
EA (1) EA025640B1 (es)
EC (1) ECSP13012384A (es)
ES (1) ES2661973T3 (es)
HR (1) HRP20180396T1 (es)
HU (1) HUE038399T2 (es)
LT (1) LT2593094T (es)
MX (1) MX337454B (es)
PE (1) PE20131063A1 (es)
PL (1) PL2593094T3 (es)
PT (1) PT2593094T (es)
SG (1) SG187016A1 (es)
SI (1) SI2593094T1 (es)
WO (1) WO2012007352A1 (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012007352A1 (de) 2010-07-12 2012-01-19 Boehringer Ingelheim International Gmbh Wässrige zusammensetzung enthaltend bromhexin
WO2014037832A2 (en) 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment of epilepsy and neurological diseases
EP2847169A4 (en) 2012-05-07 2015-09-30 Cellix Bio Private Ltd COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
JP2015522531A (ja) 2012-05-07 2015-08-06 セリックスビオ プライヴェート リミテッド 神経筋疾患及び神経変性疾患の治療のための組成物及び方法
US9399634B2 (en) 2012-05-07 2016-07-26 Cellix Bio Private Limited Compositions and methods for the treatment of depression
WO2013168023A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of parkinson's disease
WO2013168025A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of blood clotting disorders
WO2013167992A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of inflammatory disorders
US9522884B2 (en) 2012-05-08 2016-12-20 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic disorders
WO2013167993A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological degenerative disorders
US9233161B2 (en) 2012-05-10 2016-01-12 Cellix Bio Private Limited Compositions and methods for the treatment of neurological conditions
US9321775B2 (en) 2012-05-10 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of moderate to severe pain
US9346742B2 (en) 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
US9339484B2 (en) 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9394288B2 (en) 2012-05-10 2016-07-19 Cellix Bio Private Limited Compositions and methods for the treatment of asthma and allergy
WO2013168014A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of familial amyloid polyneuropathy
US9573927B2 (en) 2012-05-10 2017-02-21 Cellix Bio Private Limited Compositions and methods for the treatment of severe pain
US9273061B2 (en) 2012-05-10 2016-03-01 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
US9315478B2 (en) 2012-05-10 2016-04-19 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9315461B2 (en) 2012-05-10 2016-04-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurologic diseases
SG11201407318UA (en) 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of metabolic syndrome
WO2013168033A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for treatment of neurologic diseases
WO2013168012A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of respiratory disorders
CN104603100A (zh) 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 用于治疗炎症性肠病的组合物和方法
US9434729B2 (en) 2012-05-23 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
US9765020B2 (en) 2012-05-23 2017-09-19 Cellix Bio Private Limited Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis
WO2013175347A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of respiratory disorders
WO2013175359A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of multiple sclerosis
WO2013175376A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of local pain
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
WO2014020480A2 (en) 2012-08-03 2014-02-06 Mahesh Kandula Compositions and methods for the treatment migraine and neurologic diseases
WO2014037833A2 (en) 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment inflammation and lipid disorders
US9670153B2 (en) 2012-09-08 2017-06-06 Cellix Bio Private Limited Compositions and methods for the treatment of inflammation and lipid disorders
JP6017249B2 (ja) * 2012-09-28 2016-10-26 小林製薬株式会社 経口投与用液体医薬組成物
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
SG11201509782TA (en) 2013-06-04 2015-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
CN103893116B (zh) * 2014-04-17 2015-12-09 河北仁合益康药业有限公司 一种盐酸溴己新口服液组合物
US20170189330A1 (en) * 2014-05-23 2017-07-06 Boehringer Ingelheim International Gmbh Cough syrup containing ambroxol hydrochloride
CA2976314C (en) 2014-09-26 2021-02-23 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological disorders
AU2014407862B2 (en) 2014-09-29 2020-03-26 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
CN107108535B (zh) 2014-10-27 2020-04-28 塞尔利克斯生物私人有限公司 用于治疗多发性硬化的富马酸单甲酯与哌嗪或乙二胺的三组分盐
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9932294B2 (en) 2014-12-01 2018-04-03 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
JP6679616B2 (ja) 2015-01-06 2020-04-22 セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ 炎症及び疼痛の治療のための組成物及び方法
CN111568861A (zh) * 2020-05-25 2020-08-25 河北科星药业有限公司 畜禽用盐酸溴己新口服液及其制备方法和应用
CN111714477B (zh) * 2020-07-23 2021-06-15 山东迅达康兽药有限公司 祛痰组合物及其口服液制备方法
CN113109463B (zh) * 2021-03-16 2022-11-25 浙江工业大学 一种复方氯丙那林溴己新胶囊中有关物质的检测方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085784B2 (ja) 1987-06-17 1996-01-24 興和株式会社 シロツプ剤
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
EP0896815A4 (en) * 1996-05-02 2000-02-09 Taisho Pharmaceutical Co Ltd SUSPENSION OF A LITTLE WATER-SOLUBLE ACID MEDICINE
JP3800437B2 (ja) 1996-07-24 2006-07-26 大正製薬株式会社 苦味が軽減された液剤
JPH10101581A (ja) 1996-09-26 1998-04-21 Taisho Pharmaceut Co Ltd 塩酸ブロムヘキシンの安定化製剤及び安定化方法
JPH10306038A (ja) 1997-05-07 1998-11-17 Taisho Pharmaceut Co Ltd ブロムヘキシン含有液剤
JP2000281562A (ja) * 1999-03-30 2000-10-10 Taisho Pharmaceut Co Ltd ゲル状組成物
JP2001106639A (ja) * 1999-10-04 2001-04-17 Taisho Pharmaceut Co Ltd 経口用組成物
EP1121940A1 (en) * 2000-01-31 2001-08-08 New Pharma Research Sweden AB Pharmaceutical compositions comprising an antibiotic and bromhexine, and process for their preparation
JP2002081562A (ja) 2000-09-05 2002-03-22 Kayaba Ind Co Ltd リリーフ弁
US6692725B2 (en) * 2001-02-19 2004-02-17 Daicel Chemical Industries, Ltd. Composition for oral care
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
JP5134802B2 (ja) * 2005-09-29 2013-01-30 第一三共ヘルスケア株式会社 塩酸ブロムヘキシン含有量低下の防止方法
US10022339B2 (en) * 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
JP2008013542A (ja) * 2006-06-07 2008-01-24 Daiichi Sankyo Healthcare Co Ltd 去痰又は気道杯細胞過形成抑制のための医薬組成物
CN100409835C (zh) * 2007-04-06 2008-08-13 张嵩 含有溴己新盐的组合物及大容量注射剂和注射剂制备方法
KR101025498B1 (ko) * 2008-05-02 2011-03-31 (주)이엘티사이언스 염산브롬헥신 경구용 액제 복합조성물 및 그 제조방법
WO2012007352A1 (de) 2010-07-12 2012-01-19 Boehringer Ingelheim International Gmbh Wässrige zusammensetzung enthaltend bromhexin

Also Published As

Publication number Publication date
US20130267605A1 (en) 2013-10-10
EP2593094B1 (de) 2017-12-06
EA201201659A1 (ru) 2013-06-28
CY1120079T1 (el) 2018-12-12
ES2661973T3 (es) 2018-04-04
EA025640B1 (ru) 2017-01-30
CA2803471C (en) 2019-01-15
AR082381A1 (es) 2012-12-05
HUE038399T2 (hu) 2018-10-29
CL2012003625A1 (es) 2013-05-31
JP2013531017A (ja) 2013-08-01
LT2593094T (lt) 2018-03-26
CN103052384B (zh) 2017-04-05
SG187016A1 (en) 2013-02-28
US9220693B2 (en) 2015-12-29
WO2012007352A1 (de) 2012-01-19
DK2593094T3 (en) 2018-03-12
SI2593094T1 (en) 2018-04-30
PL2593094T3 (pl) 2018-05-30
PT2593094T (pt) 2018-03-12
CA2803471A1 (en) 2012-01-19
HRP20180396T1 (hr) 2018-04-20
EP2593094A1 (de) 2013-05-22
MX337454B (es) 2016-03-07
KR20130100091A (ko) 2013-09-09
CO6680609A2 (es) 2013-05-31
BR112013000537B1 (pt) 2021-07-27
ECSP13012384A (es) 2013-03-28
AU2011278451B2 (en) 2014-11-27
KR101943812B1 (ko) 2019-01-31
MX2013000417A (es) 2013-02-07
CN103052384A (zh) 2013-04-17
JP5979763B2 (ja) 2016-08-31
AU2011278451A1 (en) 2013-01-24
BR112013000537A2 (pt) 2016-05-24

Similar Documents

Publication Publication Date Title
PE20131063A1 (es) Composicion acuosa que contiene bromhexina
CR20150174A (es) Composición esterilizada que comprende al menos un ácido hialuronico y ascorbil fosfato de magnesio
NZ712270A (en) Pharmaceutical composition of s-ketamine hydrochloride
CL2013000815A1 (es) Composicion farmaceutica liquida de adm inistracion parenteral que comprende dexmedetomidina o una sal de la misma en una concentracion de 0,005 a 50 µg/ml y adicionalmente comprende cloruro de sodio en una concentracion de 0,01 a 2 % en peso, dispuesta dentro de un contenedor de vidrio sellado.
CL2013001589A1 (es) Uso de una emulsion que comprende 0,08% en peso o menos de aceite esencial antimicrobiano, goma acacia y agua para proporcionar un efecto antimicrobiano en una composicion acuosa; proceso para mejorar el efecto antimicrobiano de un aceite esencial antimicrobiano; y composicion acuosa que comprende una emulsion antimicrobiana.
CL2014002564A1 (es) Composiciones para tratamiento de agua que comprende un coagulante que contiene aluminio y un polisacarido no derivado natural, en donde la relacion entre el polisacarido y el coagulante es entre 1:10 hasta 1:100; y métodos de uso.
EA201400903A1 (ru) Композиции глины
EA201491605A1 (ru) Способы улучшения функции диафрагмы
PH12015500636A1 (en) Nutritional compositions including a calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
PH12015502542A1 (en) Stabilized pemetrexed formulation
ES2721474T3 (es) Hidrodispersión cosmética estable
ZA202210899B (en) Solutons for increasing the stability and shelf life of an organ and tissue preservation solution
AR092691A1 (es) Composicion farmaceutica que comprende rebamipida
PH12016501902A1 (en) Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed
PH12016501901A1 (en) Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed
BR112015000275A2 (pt) utilização de um extrato de mirta como agente anti-biopelícula face p. acnes
EA201500752A1 (ru) Способ лечения заболеваний
BR112013033060A2 (pt) solução oftálmica contendo ácido hialurônico ou sal deste e propileno glicol
AR090244A1 (es) Formulacion de anticuerpo anti-selectina p
AR097216A1 (es) Composición para el tratamiento contra el envejecimiento de la piel
MX2013008277A (es) Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora.
FR2980709B1 (fr) Compositions contenant de la spermine et compositions pharmaceutiques les contenant
EA201200754A1 (ru) Традиционное китайское лекарственное средство, содержащее экстракты дан-шен (danshen) и сан-ки (sanqi), и его применение
MX2013005306A (es) Composicion farmaceutica.
BR112015015349A2 (pt) derivado de amida de ácido cinâmico

Legal Events

Date Code Title Description
FC Refusal